{"organizations": [], "uuid": "95da73bf1e3fd7b87eaf19239f9b6fab2f83083d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.wcax.com", "main_image": "", "site_section": "http://www.wcax.com/category/50910/new-york-headlines", "section_title": "New York Headlines - WCAX.COM Local Vermont News, Weather and Sports-", "url": "http://www.wcax.com/story/30249943/new-york-ag-probes-drug-maker-accused-of-gouging-patients", "country": "US", "title": "New York AG probes drug maker accused of gouging patients", "performance_score": 0, "site": "wcax.com", "participants_count": 1, "title_full": "New York AG probes drug maker accused of gouging patients - WCAX.COM Local Vermont News, Weather and Sports-", "spam_score": 0.0, "site_type": "news", "published": "2015-10-13T03:00:00.000+03:00", "replies_count": 0, "uuid": "95da73bf1e3fd7b87eaf19239f9b6fab2f83083d"}, "author": "wcax.com", "url": "http://www.wcax.com/story/30249943/new-york-ag-probes-drug-maker-accused-of-gouging-patients", "ord_in_thread": 0, "title": "New York AG probes drug maker accused of gouging patients", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "ALBANY, N.Y. (AP) - New York Attorney General Eric Schneiderman's office is questioning a pharmaceutical company criticized last month for sharply increasing the price of treatment for a deadly parasitic infection.\nSchneiderman's anti-trust bureau wrote Monday to Turing Pharmaceuticals CEO Martin Shkreli seeking a response to concerns that the company may be \"unlawfully\" restraining competition by distributing the drug Daraprim only through a limited number of specialty pharmacies in order to prevent generic manufacturers from obtaining access to samples.\nThe letter says the New York City-based company's actions could \"impede access\" to a critically important drug.\nTuring said last month that it would reduce prices for Daraprim, used to treat toxoplasmosis, after facing criticism for hiking the price in August from $13.50 per pill to $750.\nMessages left with Turing were not initially returned.\n ", "external_links": [], "published": "2015-10-13T03:00:00.000+03:00", "crawled": "2015-10-19T13:01:44.781+03:00", "highlightTitle": ""}